INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 88 filers reported holding INSMED INC in Q3 2013. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,002,540 | +45.5% | 594,160 | +21.6% | 0.04% | +53.8% |
Q2 2023 | $10,313,089 | +32.4% | 488,772 | +7.0% | 0.03% | +18.2% |
Q1 2023 | $7,787,076 | -14.3% | 456,720 | +0.4% | 0.02% | -24.1% |
Q4 2022 | $9,091,619 | +42.3% | 455,036 | +53.4% | 0.03% | +31.8% |
Q3 2022 | $6,389,000 | +878.4% | 296,620 | +967.0% | 0.02% | +1000.0% |
Q1 2022 | $653,000 | -12.8% | 27,800 | +1.1% | 0.00% | 0.0% |
Q4 2021 | $749,000 | -91.9% | 27,500 | -91.8% | 0.00% | -90.5% |
Q3 2021 | $9,232,000 | +18.8% | 335,209 | +22.7% | 0.02% | +16.7% |
Q2 2021 | $7,773,000 | +1.6% | 273,135 | +21.6% | 0.02% | -10.0% |
Q1 2021 | $7,648,000 | +1584.6% | 224,547 | +1546.7% | 0.02% | +1900.0% |
Q4 2020 | $454,000 | -93.5% | 13,636 | -93.7% | 0.00% | -96.0% |
Q3 2020 | $6,941,000 | +59.2% | 215,962 | +36.4% | 0.02% | +13.6% |
Q2 2020 | $4,359,000 | +484.3% | 158,291 | +240.0% | 0.02% | +266.7% |
Q1 2020 | $746,000 | -39.7% | 46,555 | -10.1% | 0.01% | +50.0% |
Q4 2019 | $1,237,000 | -71.1% | 51,796 | -78.7% | 0.00% | -71.4% |
Q3 2019 | $4,285,000 | -63.7% | 242,937 | -47.4% | 0.01% | -65.0% |
Q2 2019 | $11,817,000 | +339.5% | 461,611 | +399.1% | 0.04% | +344.4% |
Q1 2019 | $2,689,000 | +493.6% | 92,491 | +168.0% | 0.01% | +350.0% |
Q4 2018 | $453,000 | -41.8% | 34,512 | -10.3% | 0.00% | 0.0% |
Q3 2018 | $778,000 | +244.2% | 38,479 | +303.3% | 0.00% | +100.0% |
Q2 2018 | $226,000 | -89.5% | 9,542 | -90.0% | 0.00% | -85.7% |
Q1 2018 | $2,159,000 | -40.4% | 95,885 | -17.4% | 0.01% | -41.7% |
Q4 2017 | $3,621,000 | -29.3% | 116,127 | -29.3% | 0.01% | -33.3% |
Q3 2017 | $5,123,000 | +1220.4% | 164,141 | +625.0% | 0.02% | +1700.0% |
Q2 2017 | $388,000 | +78.8% | 22,639 | +63.2% | 0.00% | 0.0% |
Q3 2013 | $217,000 | -86.8% | 13,873 | -89.9% | 0.00% | -91.7% |
Q2 2013 | $1,650,000 | – | 137,942 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,799,225 | $40,519,000 | 16.80% |
Foresite Capital Management II, LLC | 967,636 | $21,791,000 | 7.25% |
Palo Alto Investors LP | 7,159,590 | $161,234,000 | 6.90% |
Asymmetry Capital Management, L.P. | 162,185 | $3,652,000 | 4.57% |
NEXTHERA CAPITAL LP | 918,523 | $20,685,000 | 3.41% |
Redmile Group, LLC | 2,166,362 | $48,786,000 | 1.88% |
Orbimed Advisors | 2,927,891 | $65,936,000 | 0.82% |
Rock Springs Capital Management LP | 825,000 | $18,579,000 | 0.79% |
Bellevue Group AG | 334,489 | $7,533,000 | 0.75% |
EMERALD ADVISERS, LLC | 726,946 | $16,371,000 | 0.66% |